Galera Therapeutics Inc (GRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GRTX Annual Balance Sheets →
The table below presents a historical view of Galera Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent5.50
Cash & Short-term Investments5.00
Prepaid Expense And Other Assets Current0.56
Total Current Assets6.06
Other Assets, Noncurrent0.10
Total Assets6.16
Liabilities
Accounts Payable, Current AC0.70
Accrued Liabilities, Current AC0.44
Total Current Liabilities1.14
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Royalty Guarantees Commitments Amount-
Total Liabilities1.14
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock309.57
Retained Earnings / Accumulated Deficit-308.92
Other Equity-4.30
Common Stockholder's Equity-3.57
Preferred Stockholder's Equity4.30
Total Stockholder's Equity0.73
Liabilities & Stockholder's Equity6.16
4 historic quarters locked

Sign in to unlock the full Galera Therapeutics Inc balance sheet history.

About Galera Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001563577-26-000014

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.